Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleFEATURED ARTICLE OF THE MONTH

Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial

Melline G.M. Schilham, Diederik M. Somford, Heidi V.N. Küsters-Vandevelde, Rick Hermsen, Jean Paul A. van Basten, Robert J. Hoekstra, Tom W.J. Scheenen, Martin Gotthardt, J.P. Michiel Sedelaar and Mark Rijpkema
Journal of Nuclear Medicine March 2024, 65 (3) 423-429; DOI: https://doi.org/10.2967/jnumed.123.266495
Melline G.M. Schilham
1Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands;
2Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands;
3Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diederik M. Somford
2Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands;
3Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidi V.N. Küsters-Vandevelde
4Department of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rick Hermsen
5Department of Nuclear Medicine, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Paul A. van Basten
2Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands;
3Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J. Hoekstra
2Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands;
6Department of Urology, Catharina Hospital, Eindhoven, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom W.J. Scheenen
1Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Gotthardt
1Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.P. Michiel Sedelaar
2Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands;
7Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Rijpkema
1Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 3 423-429
DOI 
https://doi.org/10.2967/jnumed.123.266495
PubMed 
38176721

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication August 10, 2023
  • Accepted for publication November 7, 2023
  • Published online March 1, 2024.

Article Versions

  • previous version (January 4, 2024 - 06:54).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Melline G.M. Schilham1,2,3,
  2. Diederik M. Somford2,3,
  3. Heidi V.N. Küsters-Vandevelde4,
  4. Rick Hermsen5,
  5. Jean Paul A. van Basten2,3,
  6. Robert J. Hoekstra2,6,
  7. Tom W.J. Scheenen1,
  8. Martin Gotthardt1,
  9. J.P. Michiel Sedelaar2,7 and
  10. Mark Rijpkema1
  1. 1Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands;
  2. 2Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands;
  3. 3Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
  4. 4Department of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
  5. 5Department of Nuclear Medicine, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
  6. 6Department of Urology, Catharina Hospital, Eindhoven, The Netherlands; and
  7. 7Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands
  1. For correspondence or reprints, contact Melline G.M. Schilham (melline.schilham{at}radboudumc.nl).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • 11 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Evolving Paradigms in Prostate Cancer: The Integral Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging and Therapeutic Decision-Making
    Cristian Udovicich, Angela Y. Jia, Andrew Loblaw, Renu Eapen, Michael S. Hofman, Shankar Siva
    International Journal of Radiation Oncology*Biology*Physics 2025 121 2
  • Clinical Responses to Prostate-specific Membrane Antigen Radioguided Salvage Lymphadenectomy for Prostate Cancer Recurrence: Results from a Prospective Exploratory Trial
    Adam B. Weiner, Zachary Ells, Catherine Meyer, Magnus Dahlbom, David Sennung, Deepu Varughese, Vinicius B. Ludwig, Giuseppe Carlucci, Raeven Grant, Johannes Czernin, Jeremie Calais, Robert E. Reiter
    European Urology Open Science 2024 70
  • A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment
    Elio Mazzone, Donato Cannoletta, Leonardo Quarta, David C. Chen, Alice Thomson, Francesco Barletta, Armando Stabile, Daniel Moon, Renu Eapen, Nathan Lawrentschuk, Francesco Montorsi, Shankar Siva, Michael S. Hofman, Arturo Chiti, Declan G. Murphy, Alberto Briganti, Marlon L. Perera
    European Urology 2025 87 6
  • External validation of a nomogram for unilateral pelvic lymph node dissection in prostate cancer
    Gernot Ortner, Fabian Falkenbach, Mykyta Kachanov, Tim Inderhees, Tobias Maurer, Sophie Knipper, Markus Graefen, Lars Budäus
    BJU International 2025
  • Intraoperative Confocal Laser Endomicroscopy Detects Prostate Cancer at the Single-Cell Level with High Specificity and in Real Time: A Preclinical Proof of Concept
    Ann-Christin Eder, Jessica Matthias, Francois Lacombe, Lisa-Charlotte Domogalla, Antoine Jacques, Nils Steinacker, Gaetan Christien, Elodie Martin, Aline Criton, Matthias Eder
    Pharmaceuticals 2025 18 6
  • Management Based on Pretreatment PSMA PET of Patients with Localized High-Risk Prostate Cancer Part 2: Prediction of Recurrence—A Systematic Review and Meta-Analysis
    Manuela Andrea Hoffmann, Cigdem Soydal, Irene Virgolini, Murat Tuncel, Kalevi Kairemo, Daniel S. Kapp, Finn Edler von Eyben
    Cancers 2025 17 5
  • Pelvic lymph node management in prostate cancer: a narrative review
    Bryan Chong, Vincent Khor, Jing Xue Hoo, Alvin Lee, Yu Guang Tan, Henry Ho, Christopher Cheng, Kae Jack Tay, Jeffrey Tuan, John Yuen, Kenneth Chen
    Prostate International 2025
  • Radioguided Surgery for Prostate Cancer
    Leonardo Quarta, Armando Stabile, Arturo Chiti, Francesco Montorsi, Alberto Briganti, Giorgio Gandaglia
    European Urology Focus 2025
  • Sterke correlatie tussen de intensiteit van prostaatkankerrecidieven op de PSMA PET/CT-scan en het intra-operatieve gammasonde signaal
    Anne-Claire Berrens, Malou A. Sorbi, Maarten L. Donswijk, Hilda A. de Barros, Samaneh Azargoshasb, Matthias N. van Oosterom, Daphne D. D. Rietbergen, Elise M. Bekers, Henk G. van der Poel, Fijs W. B. van Leeuwen, Pim J. van Leeuwen
    Tijdschrift voor Urologie 2024 14 8
  • The DETECT Trial: Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
    Tobias Maurer, Christian Thomas, Boris Hadaschik
    Journal of Nuclear Medicine 2024 65 3

Article usage

Article usage: January 2024 to April 2025

AbstractFullPdf
Jan 20241433463149
Feb 202420720068
Mar 20245851175319
Apr 2024150668182
May 202411020554
Jun 20247718367
Jul 20245031351
Aug 20243727957
Sep 20243514134
Oct 20242618951
Nov 20244619448
Dec 20242515377
Jan 20252511970
Feb 20252914755
Mar 20252711648
Apr 20251810180
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (3)
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial
Melline G.M. Schilham, Diederik M. Somford, Heidi V.N. Küsters-Vandevelde, Rick Hermsen, Jean Paul A. van Basten, Robert J. Hoekstra, Tom W.J. Scheenen, Martin Gotthardt, J.P. Michiel Sedelaar, Mark Rijpkema
Journal of Nuclear Medicine Mar 2024, 65 (3) 423-429; DOI: 10.2967/jnumed.123.266495

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial
Melline G.M. Schilham, Diederik M. Somford, Heidi V.N. Küsters-Vandevelde, Rick Hermsen, Jean Paul A. van Basten, Robert J. Hoekstra, Tom W.J. Scheenen, Martin Gotthardt, J.P. Michiel Sedelaar, Mark Rijpkema
Journal of Nuclear Medicine Mar 2024, 65 (3) 423-429; DOI: 10.2967/jnumed.123.266495
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study
  • MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
  • IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Show more FEATURED ARTICLE OF THE MONTH

Similar Articles

Keywords

  • lymph node dissection
  • prostate cancer
  • PSMA
  • radioguided surgery
SNMMI

© 2025 SNMMI

Powered by HighWire